| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |